Evolutive study of relapsing-remitting multiple sclerosis with cervical proton magnetic resonance spectroscopy: A case report

Neuroradiology Journal

Volumn 21, Issue 4, 2008, Pages 511-517

  Riccioli, Luca Albini ^a   Marliani, A F ^a   Clementi, V ^a   Bartolomei, I ^a   Agati, R ^a   Leonardi, M ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

3 Tesla; Metabolite quantification; Proton magnetic resonance spectroscopy; Relapsing remitting multiple sclerosis; Spinal cord

Indexed keywords

CHOLINE; CONTRAST MEDIUM; CREATINE PHOSPHATE; INOSITOL; METHYLPREDNISOLONE; N ACETYLASPARTIC ACID;

AGED; ANAMNESIS; ARM WEAKNESS; ARTICLE; BABINSKI REFLEX; CASE REPORT; CERVICAL SPINE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; DOSE RESPONSE; FEMALE; GLIOSIS; HEMIPLEGIA; HUMAN; HYPESTHESIA; IMAGE ANALYSIS; INFLAMMATION; METABOLITE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPEAT PROCEDURE; SPINE RADIOGRAPHY; THREE DIMENSIONAL IMAGING; VIBRATION SENSE;

EID: 55049126769     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140090802100407     Document Type: Article

References (19)

1. Narayana PA: Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 15: 46S-56S, 2005.
2. Bhakoo KK, Pearce D: In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74: 254-262, 2000.
3. Jung RE, Yeo RA, Chiulli SJ et Al: Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. Neuroreport 10: 3327-3331, 1999.
4. Ross BD, Ernst T, Kreis R et Al: 1H MRS in acute traumatic brain injury. J Magn Reson Imaging 8: 829-840, 1998.
5. Leary SM, Davie CA, Parker GJ et Al: 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J Neurol 246: 1023-1026, 1999.
6. De Stefano N, Matthews PM, Antel JP et Al: Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38: 901-909, 1995.
7. Arnold DL, Matthews PM, Francis GS et Al: Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 31: 235-241, 1992.
8. Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 21: 1645-1649, 2000.
9. Saraf-Lavi E, Bowen BC, Pattany PM et Al: Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels. Am J Neuroradiol 24: 782-784, 2003
10. Vrenken H, Barkhof F, Uitdehaag BM et Al: Spectroscopic evidence for glial increase but not for neuro- axonal damage in MS normal-appearing white matter. Magn Reson Med 53: 256-266, 2005.
11. Fernando KT, McLean MA, Chard DT et Al: Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127: 1361-9, 2004.
12. Bitsch A, Bruhn H, Vougioukas V et Al: Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. Am J Neuroradiol 20: 1619-27, 1999.
13. Kendi ATK, Tan FU, Kendi M et Al: MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46: 764-769, 2004.
14. Henning A, Schar M, Kollias SS et Al: Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med published on line 2008.
15. Marliani AF, Clementi V, Albini Riccioli L et Al: Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 57: 160-3, 2007.
16. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679, 1993.
17. Davie CA, Barker GJ, Webb S et Al: Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 117: 49-58, 1994.
18. Davie CA, Hawkins CP, Barker GJ et Al: Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117: 49-58, 1994.
19. Narayana PA, Doyle TJ, Lai D et Al: Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43: 56-71, 1998.